Clinical Trial Update: NPC Study : TAX + CIS Neoadjuvant in Patients With Loco Regionally Advanced Undifferentiated Carcinoma of Nasopharyngeal Type (UCNT) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update indicates completion of a neoadjuvant regimen with docetaxel and cisplatin in locally advanced undifferentiated carcinoma of the n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Sanofi | Conditions: Head and Neck Neoplasms | Phase 2 | Status: COMPLETED